- Home
- FITB vs TEVA Comparison
FITB vs TEVA Comparison
Compare FITB & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FITB | TEVA |
|---|---|---|
| Founded | 1858 | 1901 |
| Country | United States | Israel |
| Employees | 18676 | 32842 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.0B | 33.5B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | FITB | TEVA |
|---|---|---|
| Price | $44.43 | $28.37 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 8 |
| Target Price | ★ $54.38 | $37.38 |
| AVG Volume (30 Days) | ★ 9.0M | 7.0M |
| Earning Date | 04-17-2026 | 04-29-2026 |
| Dividend Yield | ★ 3.59% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $55.38 | N/A |
| Revenue Next Year | $6.85 | $2.51 |
| P/E Ratio | ★ $15.20 | $28.19 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $32.25 | $12.47 |
| 52 Week High | $55.44 | $37.35 |
Technical Indicators
Market Signals| Indicator | FITB | TEVA |
|---|---|---|
| Relative Strength Index (RSI) | 37.83 | 33.82 |
| Support Level | $40.68 | $24.01 |
| Resistance Level | $46.59 | $31.99 |
| Average True Range (ATR) | 1.02 | 0.94 |
| MACD | 0.18 | -0.04 |
| Stochastic Oscillator | 44.30 | 3.16 |
Price Performance
Historical ComparisonAbout FITB Fifth Third Bancorp
Fifth Third Bancorp is a midsize regional bank in the US, with total assets of over $210 billion as of December 2025. The bank is set to close its acquisition of Comercia on Feb. 1, 2026. Headquartered in Cincinnati, Ohio, Fifth Third has a strong presence in the US Midwest and is currently expanding in the US Southeast. The bank provides a diversified set of financial services in retail banking, commercial banking, card and Treasury management, wealth and asset management, and capital markets.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.